oTraces.net
About oTraces.net
OTraces, Inc. has combined two highly innovative technology developments to produce practical specific and sensitive screening blood tests for cancer for the first time, including Breast, Ovarian, Prostate, Lung and other cancers. First, a new ultra-sensitive protein detection technology has been developed that is several hundred times more sensitive than current methods.
Categories:
- Document
- Untitled
- Abundance
- Approach
- Biomarkers
- Blood
- Both
- Breast
- Cancer
- Cancers
- Combined
- Critical
- Current
- Depends
- Detection
- Developed
- Developments
- Diagnosis
- Diagnostic
- Evaluated
- Evaluating
- Exceeds
- Highly
- Hundred
- Inc
- Including
- Innovative
- Invasive
- Laps
- Level
- Lung
- Method
- Methods
- Next
- Non
- Noted
- Novel
- Oncology
- Otraces
- Ovarian
- Performance
- Potential
- Practical
- Produce
- Prostate
- Protein
- Proteins
- Quantify
- Result
- Results
- Screening
- Sensitive
- Several
- Specific
- Technology
- Test
- Tests
- Times
- Ultra
- Ultrasensitive
- Women